Stock 2616 CSTONE PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Revisions CStone Pharmaceuticals

Equities

2616

KYG2588M1006

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:15 2024-04-18 am EDT 		5-day change 1st Jan Change
0.9 HKD +4.65% Intraday chart for CStone Pharmaceuticals +5.88% -60.35%
Apr. 09 China Accepts CStone Pharmaceuticals' Manufacturing Application for RET Inhibitor MT
Apr. 09 CStone Announces the Availability of RET Inhibitor GAVRETO® Manufacturing Localization Application by Center for Drug Evalence of China NMPA CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. 2616 Stock
  4. Revisions CStone Pharmaceuticals